Pseudoephedrine-induced hypertensive emergency: treatment with labetalol.Am J Emerg Med. 1986 Mar; 4(2):141-2.AJ
Abstract
The case of a young man in hypertensive emergency following the ingestion of 840 mg of pseudoephedrine is reported. The hypertension, which peaked at 200/160 mm Hg and was associated with severe headache and diaphoresis, responded expeditiously to two initial intravenous doses of labetalol. No rebound was observed following the administration of an additional dose in the intensive care unit, after which an uneventful one-day hospitalization ensued. The toxicity of pseudoephedrine is briefly reviewed along with the pharmacology and use of labetalol. On the basis of previous experimental studies and the present report, labetalol is suggested as a promising agent in the treatment of hyperadrenergic-induced hypertensive emergencies.
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
3947442
Citation
Mariani, P J.. "Pseudoephedrine-induced Hypertensive Emergency: Treatment With Labetalol." The American Journal of Emergency Medicine, vol. 4, no. 2, 1986, pp. 141-2.
Mariani PJ. Pseudoephedrine-induced hypertensive emergency: treatment with labetalol. Am J Emerg Med. 1986;4(2):141-2.
Mariani, P. J. (1986). Pseudoephedrine-induced hypertensive emergency: treatment with labetalol. The American Journal of Emergency Medicine, 4(2), 141-2.
Mariani PJ. Pseudoephedrine-induced Hypertensive Emergency: Treatment With Labetalol. Am J Emerg Med. 1986;4(2):141-2. PubMed PMID: 3947442.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Pseudoephedrine-induced hypertensive emergency: treatment with labetalol.
A1 - Mariani,P J,
PY - 1986/3/1/pubmed
PY - 1986/3/1/medline
PY - 1986/3/1/entrez
SP - 141
EP - 2
JF - The American journal of emergency medicine
JO - Am J Emerg Med
VL - 4
IS - 2
N2 - The case of a young man in hypertensive emergency following the ingestion of 840 mg of pseudoephedrine is reported. The hypertension, which peaked at 200/160 mm Hg and was associated with severe headache and diaphoresis, responded expeditiously to two initial intravenous doses of labetalol. No rebound was observed following the administration of an additional dose in the intensive care unit, after which an uneventful one-day hospitalization ensued. The toxicity of pseudoephedrine is briefly reviewed along with the pharmacology and use of labetalol. On the basis of previous experimental studies and the present report, labetalol is suggested as a promising agent in the treatment of hyperadrenergic-induced hypertensive emergencies.
SN - 0735-6757
UR - https://www.unboundmedicine.com/medline/citation/3947442/Pseudoephedrine_induced_hypertensive_emergency:_treatment_with_labetalol_
DB - PRIME
DP - Unbound Medicine
ER -